Fate Therapeutics names Jamie Harrell as commercial operations chief
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.15 -0.03 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.18 | 52 Week High | $4.76 | |||
| Open | $2.13 | 52 Week Low | $1.46 | |||
| Day High | $2.18 | P/E | N/A | |||
| Day Low | $2.10 | EPS | $-1.91 | |||
| Volume | 266,864 | |||||
